ACE and infection: If indeed a single peptide product of ACE is responsible for enhancing the immune response to tumors, infection, and chronic diseases such as atherosclerosis and AD, then having the sequence of the responsible peptide would play into a strength of the pharmaceutical industry, namely, developing a nonpeptide analog.